Tuesday, Jun 17

A $7.4 billion settlement has been reached to end Sackler family's control over Purdue Pharma, addressing the opioid crisis in the US.

Thursday, May 15

Drug overdose deaths in the U.S. fell by 27% in 2024, marking the largest annual decline recorded.

Tuesday, Apr 22

Walgreens settles opioid prescription allegations for $300 million, agreeing to enhanced compliance measures and avoiding further litigation.

Thursday, Mar 20

Purdue Pharma files a new bankruptcy plan proposing a $7.4 billion settlement in response to opioid crisis lawsuits, aiming to benefit victims and communities.

Wednesday, Feb 05

Explore the complexities of the U.S. fentanyl crisis, including the China-Mexico trafficking pipeline, tariffs, and ineffective border control strategies.

Sunday, Feb 02

The FDA has approved Journavx, a new non-opioid pain medication, aiming to combat opioid addiction and overdose risks in patients.

Friday, Jan 31

The FDA has approved Journavx, a groundbreaking non-opioid painkiller, marking the first new class in over 20 years, aiming to eliminate the risks of opioid addiction.

Saturday, Jan 25

Purdue Pharma and the Sackler family reach a $7.4 billion settlement to resolve lawsuits related to the opioid crisis and OxyContin's toll in the U.S.

Friday, Jan 24

Purdue Pharma and the Sackler family agree to a $7.4 billion settlement to address ongoing lawsuits related to the opioid epidemic, marking a significant resolution in the crisis.

Saturday, Jan 18

The U.S. Justice Department has filed a lawsuit against Walgreens, accusing the pharmacy chain of filling millions of illegitimate opioid prescriptions.